Cleared Traditional

K061350 - LITHODIAMOND ULTRA (FDA 510(k) Clearance)

Class II Gastroenterology & Urology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K061350 · Pck Electronic Industry & Trade Co., Ltd. · Gastroenterology & Urology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2006
Decision
221d
Days
Class 2
Risk

K061350 is an FDA 510(k) clearance for the LITHODIAMOND ULTRA. Classified as Lithotriptor, Extracorporeal Shock-wave, Urological (product code LNS), Class II - Special Controls.

Submitted by Pck Electronic Industry & Trade Co., Ltd. (Washington, US). The FDA issued a Cleared decision on December 22, 2006 after a review of 221 days - an extended review cycle.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.5990 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Gastroenterology & Urology review framework, consistent with the majority of Class II 510(k) submissions.

View all Pck Electronic Industry & Trade Co., Ltd. devices

Submission Details

510(k) Number K061350 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 15, 2006
Decision Date December 22, 2006
Days to Decision 221 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
91d slower than avg
Panel avg: 130d · This submission: 221d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LNS Lithotriptor, Extracorporeal Shock-wave, Urological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.5990
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Gastroenterology & Urology devices follow this clearance model.

Regulatory Peers - LNS Lithotriptor, Extracorporeal Shock-wave, Urological

All 55
Devices cleared under the same product code (LNS) and FDA review panel - the closest regulatory comparables to K061350.
Break Wave
K261086 · Sonomotion, Inc. · Apr 2026
Break Wave
K252913 · Sonomotion, Inc. · Jan 2026
Extracorporeal Shock Wave Lithotripter (U200)
K242922 · Shenzhen Wikkon Precision Technologies Co., Ltd. · Jun 2025
Delta III Pro
K221903 · Dornier Medtech America, Inc. · Feb 2023
LM-9300 Plus Lithotripter
K213772 · Lite-Med, Inc. · Jan 2023